Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Non-small cell lung cancer"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Zhou%2C+Jianying%22&type=Person&filter%5B%5D=topic_facet%3A%22Non-small+cell+lung+cancer%22
/vufind/Search/Results?lookfor=%22Zhou%2C+Jianying%22&type=Person&filter%5B%5D=topic_facet%3A%22Non-small+cell+lung+cancer%22
Search /vufind/Search2/Results?lookfor=%22Zhou%2C+Jianying%22&type=Person&filter%5B%5D=topic_facet%3A%22Non-small+cell+lung+cancer%22
PubPharm (12)
1
Sintilimab versus docetaxel as second-line treatment in advanced or metastatic squamous non-small-cell lung cancer : an open-label, randomized controlled phase 3 trial (ORIENT-3)
enthalten in:
Cancer communications (London, England)
| 2022
von
Shi, Y.
|
Wu, L.
|
Yu, X.
| +43
Wird geladen...
2
Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients
enthalten in:
Cancer immunology, immunotherapy : CII
| 2021
von
Chen, X.
|
Fang, L.
|
Zhu, Y.
| +10
Wird geladen...
3
Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients
enthalten in:
Cancer immunology immunotherapy
| 2021
von
Chen, X.
|
Fang, L.
|
Zhu, Y.
| +10
Wird geladen...
4
Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients
enthalten in:
Cancer immunology immunotherapy
| 2021
von
Chen, X.
|
Fang, L.
|
Zhu, Y.
| +10
Wird geladen...
5
Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients
enthalten in:
Cancer immunology immunotherapy
| 2021
von
Chen, X.
|
Fang, L.
|
Zhu, Y.
| +10
Wird geladen...
6
Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer : Results from a randomized, open-label, phase 3 trial (ARCHER 1050)
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2021
von
Cheng, Y.
|
Mok, T.
|
Zhou, X.
| +17
Wird geladen...
7
Effectiveness and prognostic factors of first-line crizotinib treatment in patients with ROS1-rearranged non-small cell lung cancer : A multicenter retrospective study
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2020
von
Zheng, J.
|
Cao, H.
|
Li, Y.
| +7
Wird geladen...
8
Progress on the Study of PD-L1 Detection Methods in Non-small Cell Lung Cancer
enthalten in:
Zhongguo fei ai za zhi = Chinese journal of lung cancer
| 2019
von
Guo, X.
|
Cao, H.
|
Zhou, J.
| +1
Wird geladen...
9
Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2018
von
Si, X.
|
Zhang, L.
|
Wang, H.
| +19
Wird geladen...
10
Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment
enthalten in:
BMC cancer
| 2018
von
Zhou, J.
|
Zheng, J.
|
Zhang, X.
| +9
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Non-small cell lung cancer
Medienart
12
Aufsätze
11
E-Artikel
11
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
3
BMC cancer
3
Cancer immunology immunotherapy
3
Lung cancer (Amsterdam, Netherlands)
1
Cancer communications (London, England)
1
Cancer immunology, immunotherapy : CII
1
Zhongguo fei ai za zhi = Chinese journal of lun...
Alle anzeigen ...
weniger ...
Thema
Non-small cell lung cancer
7
Journal Article
5
Research Support, Non-U.S. Gov't
4
Capture-based targeted sequencing
4
Crizotinib
4
Immune-checkpoint inhibitors
4
Tumor mutation burden
3
ALK
3
Clinical Trial, Phase III
3
EC 2.7.10.1
3
Efficacy
3
Multicenter Study
3
Pemetrexed
3
Randomized Controlled Trial
2
53AH36668S
2
Biomarkers, Tumor
2
Protein Kinase Inhibitors
1
04Q9AIZ7NO
1
15H5577CQD
1
49DFR088MY
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7
2020-
5
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
11
Englisch
1
Chinesisch
Haven't found what you're looking for?
Wird geladen...